Fundraising FoxSCI Ventures — Full Portfolio
16 tracked investments · listed companies and verified rows first
Groww is an investment platform that allows users to buy and sell exchange-traded funds (ETFs) through an online portal.
FintechBengaluru, IN
Lalit Keshre(CEO)inIshan Bansal(Founder)inHarsh Jain(COO)inNeeraj Singh(Founder)in
BoardAnu Hariharan(Director)inAshish Agrawal(Nominee Director)
Co-investorsAlkeon InnovationEnsemble VCFrialeICONIQInsignia Ventures PartnersPeak XV Partners+11 more
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Harold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)inDaniel Mikol(Executive Officer)inAdam Rogersin
Co-investorsCWRU Technology Ventures
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
Bik.ai builds an AI-powered CRM platform for ecommerce brands to manage marketing, customer support, and sales through conversational AI agents.
AI & Machine LearningE-commerceEnterprise SoftwareSaaSSan Francisco, US
Sonakshi Nathani(Founder)inAshutosh Singla(Founder)inASHUTOSH SINGLA(Founder)inAnushka Saha(Recruiter)Harika Bondili(Recruiter)
Co-investorsPioneerY CombinatorMantis CapitalPeak XV PartnersVenture Investment AssociatesVentureSouq
Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders.
BiotechDeep TechDigital HealthParis, FR
Philippe Chambon MD, PhD(Founder)inPhilippe Chambon(Founder, Chairman & CEO)Alberto Epstein(Founder & CSO)Cornelia Haag-Molkenteller(CMO)Samuel Salot(COO)Marc Grasso(CFO)
Co-investorsBpifranceM VenturesAndera Partners
Drip provides trade financing and working capital solutions for small and midsize businesses conducting cross-border commerce, using automated underwriting and transaction processing to assess credit and connect borrowers with capital providers and logistics partners.
FintechMH, IN
Pushkar Mukewar(CEO)inNeil Kothari(CEO)Yash Kothari(New Business Development)inNaqiyah Sohagpurwalla(Recruiter)Chanchal Singh(HR Lead)
Co-investorsAccelBetter Tomorrow VenturesBragiel BrothersDYDX CapitalEndeavor8GMO VenturePartners+19 more
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB
Tim Guilliams(Founder)inDr David Brown(Co-Founder and Board member)inDavid J. Brown(Founder)in
Co-investorsAmadeus Capital PartnersAurum Venture PartnersBalderton CapitalCambridge Angels groupDaniel GutenbergGlobal Brain+4 more
Khatabook provides a mobile app that allows business owners to digitally record customer credit and debit transactions, replacing paper ledgers; the platform also offers access to lending services and is designed for small businesses managing customer accounts.
FintechBengaluru, IN
Ravish Naresh(CEO)inAshish Sonone(Founder)Gaurav Lahoti(Founder)Jaideep Poonia(Founder)Rishabh Gupta(Founder)Vaibhav Kalpe(Founder)
Co-investorsAlkeon InnovationAlpha Wave GlobalAngel Collective Opportunity FundB Capital GroupB4 CapitalBetter Capital+30 more
.jpeg){kind=logo}
Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts.
Deep TechDigital HealthHealthtechMedical DevicesNew York, US
Benjamin Rapoport(President, Chief Science Officer)inMichael Mager(Chief Executive Officer)inCraig Mermel(President and Chief Product Officer)inMIchael Kaswan(Chief Financial Officer)Konstantinos Alataris(President)inBenjamin Rapoport Michael Mager(Founder)
Co-investorsAlumni VenturesB Capital GroupB4 CapitalBasecamp FundDraper AssociatesForepont Capital Partners+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AugmentalAxonisCraighospitalEgOnwardOnward MedicalSania Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.